Publications by authors named "M Emanuelli"

NAD-dependent deacetylase sirtuin-1 (Sirt1) belongs to the sirtuins family, known to be longevity regulators, and exerts a key role in the prevention of vascular aging. By aging, the expression levels of Sirt1 decline with a severe impact on vascular function, such as the rise of endothelial dysfunction, which in turn promotes the development of cardiovascular diseases. In this context, the impact of Sirt1 activity in preventing endothelial senescence is particularly important.

View Article and Find Full Text PDF

Oral Squamous Cell Carcinoma (OSCC) is the most common cancer arising from squamous epithelium in the oral cavity and is characterized by high aggressiveness and metastatic potential, which together with a late diagnosis results in a 5-year survival rate of only 50% of patients. The therapeutic options for OSCC management are limited and largely influenced by the cancer stage. While radical surgery can be curative in early stage of disease, most cases require adjuvant therapies, including chemotherapy and radiotherapy which, however, often achieve poor curative rates and are associated with important negative effects.

View Article and Find Full Text PDF
Article Synopsis
  • Clear cell renal cell carcinoma (ccRCC) is a common type of kidney cancer that is hard to treat because it often doesn’t respond well to chemotherapy and radiation.
  • Scientists are looking for new ways to detect and treat this cancer, focusing on a protein called paraoxonase-2 (PON2) that might help the cancer cells survive and grow.
  • In experiments, when PON2 was reduced in kidney cancer cells, the cells grew slower, moved less, and were more sensitive to chemotherapy, showing that targeting PON2 could be a promising way to fight ccRCC.
View Article and Find Full Text PDF

Merkel cell carcinoma (MCC) is an aggressive skin cancer, with a propensity for early metastasis. Therefore, early diagnosis and the identification of novel targets become fundamental. The enzyme nicotinamide N-methyltransferase (NNMT) catalyzes the reaction of N-methylation of nicotinamide and other analogous compounds.

View Article and Find Full Text PDF

Background: Osteosarcoma (OS) is a primary bone malignancy that mostly affects young people, characterized by high metastatic potential, and a marked chemoresistance that is responsible for disease relapse in most patients. Therefore, it is necessary to identify novel molecules to setup targeted strategies to improve the clinical outcome. The enzyme nicotinamide N-methyltransferase (NNMT) catalyses the N-methylation of nicotinamide and other analogs, playing a crucial role in the biotransformation of drugs and xenobiotics.

View Article and Find Full Text PDF